Publications Books of Dr.Robert Gorter ,MD, PhD About Fighting Cancer

Robert Gorter, MD, PhD

Publications 

Books: 

Robert Gorter, MD, PhD and Erik Peper, PhD: “Fighting Cancer” a Non-Toxic Approach in Cancer Therapy, Publ: North Atlantic, Berkeley, California USA. April 2011. (is being translated and published in 16 other languages).

Robert Gorter, MD, PhD, Erik Peper, PhD: “Ik heb kanker: wat nu?” -nieuwe niet-toxische therapieen- Publ: Ankh-Hermes, Utrecht, Netherlands, September 2011. ISBN: 978902020553.

Robert Gorter, MD, PhD, and Erik Peper, PhD: “Kanseri nasil Yenerim” –Tedaviye Gertirilen Toksik Olmayan Bir Yaklasim Nobel Ödüllü Yeni Yöntem- Publ: Anadolu, Turkey, January 2012. Siparis No: A5080.

Robert Gorter, MD, PhD, Erik Peper, PhD: Ich habe Krebs: was nun?”  -Ein Ratgeber zu nicht-toxischen Behandlungsmöglichkeiten- Publ: Anadolu, Germany, April 2012. ISBN: 978161215073.

Original Articles

1.           Gorter R., “Een visie vanuit de antroposofie op ‘slecht slapen’ (Insomnia from an Anthroposophic Point of View)”, Tijdschrift voor Alcohol, Drugs en Andere Psychotrope Stoffen, The Royal General Foundation for the Treatment of Abuse in Alcohol and Drugs, the Hague, t.alc.drugs (8) 4, 1982

2.           Abrams D., Kuno S., Wong R., Jeffords K., Nash M., Molaghan J., Gorter R., Ueno R., Oral dextran sulfate (UA001) in the treatment of the acquired im­mu­nodeficiency syndrome (AIDS) and AIDS-related complex. Ann Intern Med 110:3, 1989

3.           Hersh EM., Brewton G., Abrams D., Bartlett J., Gorter R., et al. Ditiocarb Sodium (Diethyldithiocarbamate) Therapy in Patients with Symptomatic HIV infection and AIDS. JAMA 265 (12):1538-1544, 1991

4.           Gorter RW., Management of anorexia-cachexia associated with cancer and HIV infection. Oncology 5(9):13-17, 1991

5.           Plasse TF., Gorter RW, Krasnow SH, et al. Recent clinical experience with dronabinol. Pharmacol Biochem Behav; 40. 695-700, 1991

6.           Gorter RW., Seefried M., Volberding P., Dronabinol effects on weight in
patients with HIV infection. AIDS 6:127-128, 1992

7.           Slome L., Moulton J., Gorter R., Abrams D., Physicians’ attitudes toward
assisted suicide in AIDS. AIDS 5:712-718, 1992

8.           Gorter R., Vranizan K., Osmond D., Moss AR. Differences in laboratory
values in HIV infection by sex, race and risk group. AIDS 6:1341-1347, 1992

9.           Moss AR., Vranizan K., Gorter R., Bacchetti P., Osmond D., HIV seroconversion in intravenous drug users in San Francisco, 1985 – 1990, AIDS 8: 223-231, 1994

10.         Zolopa AR.; Hahn A.; Gorter R.; Miranda J.; Wlodarczyk D.; Moss AR., HIV and Tuberculosis Infection in San Francisco’s Homeless Adults. JAMA; 272: 455-461, 1994

1. Mainka C., Wolff MH., Gorter R.; Vergleichende Untersuchung zum Nachweis von HIV-1-p24-Antigen mittels Enzymimmunoassay mit und ohne Immunkomplex-Dissoziation in Seren HIV-positiver Probanden. (Comperative examination to determine HIV-1-p24-antigen by means of enzyme immunoassay, with and without dissociation of antigen-antibody complex in sera of HIV-positive test subjects). Lab med 18: 508-511, 1994

1. Gorter R., Stein J., Stoss M., Linder M.; Prospektive, longitudinale, dosis-eskalierende, randomisierte Phase I/II Studie mit Iscador® QuFrF und Iscador® Qu Spezial mit HIV-Positiven, Krebspatienten und gesunden, nichtrauchenden Probanden. Forsch Komplementärmed 3: 169-175, 1996

1. M. Stoss, E. Peter, M. Schnelle, M. Werner, R.W. Gorter, Viscum album QuFrF in HIV-positives and AIDS patients. 12th World AIDS Conference, Geneva , Switzerland, 1998.

1. Gorter, R.W., Stoss M., Wollina W., Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador). Am. J. Therapeutics, 5; 181 – 187, 1998.

1. Stoss M., Gorter R.W., No evidence of IFN-y increase in the serum of HIV-positive and healthy subjects after subcutaneous injection of a non-fermented Viscum album L. extract. Natural Immunity; 16; 157-164. 1998.

1. Stoss M., Peter E., Gorter R. W., Decrease of activated lymphocytes four and nine hours after a subcutaneous injection of a Viscum album L. extract in healthy volunteers. Nat Immun 16 (5-6): 185-197, 1998.

1. van Wely, M., Stoss M., Gorter R.W., Toxicity of a standardized mistletoe extract in immunocompromized and in healthy individuals, Am. J. Therapeutics; 6 (1): 37 – 43, 1999.

1. Stoss M., van Wely M., Musielsky H., Gorter R.W., Study on Local Inflammatory Reactions and other Parameters during Subcutaneous Mistletoe Application in HIV-positive Patients and HIV-negative Subjects over a Period of 18 Weeks. Arzneim. Forsch./Drug Res. 49 (I), Nr. 4, 366 – 373, 1999.

1. Stoss M., Peter E., Gorter R.W., Decrease of activated lymphocytes 4 hours respective 9 hours after a subcutaneous injection of a Viscum album L.-extract in healthy volunteers. Natural Immunity 1998; 16:185-197.

1. Robert W. Gorter, MD, PhD, Madelon van Wely MS, Marcus Reif, PhD, Matthias Stoss, MD.: Tolerability of a Standardized, Non-Fermented Aqueous Viscum album L. Extract in Immunocompromised and Healthy Individuals: Alternative Therapies 1999; Vol. 5, Nr. 6, 37-48.

1. R. W. Gorter, Cancer Cachexia and Cannabinoids; Forsch Komplementärmed 1999; 6: 21-22.

1. M. Schnelle, F. Grotenhermen, M. Reif, R. W. Gorter; Ergebnisse einer standardisierten Umfrage zur medizinischen Verwendung von Cannabis-produkten im deutschen Sprachraum. Forsch Komplementärmed 1999; 6: 28-36.

1. W. Stuecker, AS Bihari, RW Gorter; Ozontherapie zur Immunmodulation bei HIV-Infektion. AKODH 2000; 6: 74-82 (ISSN 1435-0327).

1. Stoss M., Michels M., Peter E., Beutke R., Gorter RW; Prospective cohort trial of Euphrasia single-dose eye drops in conjunctivitis. J Altern Complement Med 2000 Dec; 6(6): 499-508.

1. Killestein J, Hoogervorst ELJ, Reif M, Lalkers NF, van Loenen AC, Staats PGM, Gorter RW, Uitdehaag BMJ, Polman CH: Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology 2002;58:1404-1407.

1. Gorter RW, Joller P, Stoss M: Cytokine Release of a Keratinocyte Model after Incubation with two different Viscum album L. Extracts. Am J Ther 2003; 10:40-47.

1. Robert W. Gorter, Mario Butorac, Eloy Pulido Cobian, Ulrich Meyer: Anwendungsbeobachtung WALA Euphrasia Augentropfen. Der Merkurstab 2004;57 (2): 135-138.

1. R.W. Gorter: Erfahrungen mit Dronabinol (Tetrahydrocannbinol) bei onkologischen Patienten mit Anorexie-Kachexie-Syndrom. Der Schmerz 2004; Vol 18;suppl 2: 31-33.

1. Gorter, Robert W., Butorac, Mario, Cobian, Eloy Pulido: Examination of the Cutaneous Absorption of Copper After the Use of Copper-Containing Ointments. American Journal of Therapeutics: 11(6): 453-458, November/December 2004.

1. Gorter, Robert W., Butorac, Mario, Cobian, Eloy Pulido: Cutaneous Resorption of Lead After External Use of Lead-Containing Ointments in Volunteers with Healthy Skin. American Journal of Therapeutics 12(1): 17-21, January/February 2005.

1. Robert W. Gorter, MD, PhD; Mario Butorac, MA; Eloy Pulido, MD; Willem van der Sluis, PhD: Medical use of Cannabis in the Netherlands. Neurology: Mar 8, 2005;64 (5): 917-919.

1. Robert W. Gorter, Eloy Pulido, Daniela Hudi, Eva-Maria Turnwald, Montassar Cherif: “Anthroposophically-Extended Medicine” Jana Council for Scientific Development (JCSD) and the Kadota Fund International Forum 2011 Kyoto, Japan. February 12th – 14th, 2011; Abstract Book:16-17 

Book Chapters

1.           Gorter R., Transmission of HIV in Intravenous Drug Users. San Francisco General Hospital AIDS Knowledge Base (computer data base). Philip T.
Cohen, Merle A. Sande, Paul Volberding, eds. Waltham, MA: Massachusetts Medical Society, 1991.

2.           Gorter R., Transmission of HIV in Intravenous Drug Users. In the AIDS Knowledge Base. Philip T. Cohen, Merle A. Sande, Paul Volberding, eds. Waltham, MA:  Massachusetts Medical Society, 1991.

1. Gorter R., Cannabis: Schmerztherapie (noch) in der Illegalität. In Schmerz Praxis Ratgeber/ZDF Gesundheitsmagazin. J. Apfelbach (Hrsg.) Einhorn
   Presse Verlag 1996. ISBN 3-88756-800-1.

1. Robert Gorter, Erfahrungen mit Dronabinol (Delta 9 Tetrahydrocannabinol) bei onkologischen Patienten mit Anorexie-Kachexie-Syndrom in Der Schmerz (Dezember 2004) 18(suppl.2); S31-S33. Springer Verlag.

1. Robert Gorter, Mehr Lebensqualität für Patienten in ultimativen Situationen. In: 1. Colloquium Dronabinol-Therapie 2003. Delta-9-Pharma. 

Overview Articles 

1. Gorter RW., Consciousness of the Newborn, Intermediair, Elsevier/Excerpta Medica, Amsterdam, 1974.

1. Gorter RW., Bos TW. Acupuncture – a real treatment for addicts? The Royal General Foundation for the Treatment of Abuse in Alcohol and Drugs, The Hague, 1977.

1. Gorter RW., Violations of human rights:  torture and the medical profession. Medisch Contact, The Royal Dutch Medical Association, Utrecht, June, 1978.

1. Robert Gorter., Management of Anorexia-Cachexia in Advanced HIV Disease. Clinical Notes, PAACNOTES , volume 3, number 5, 1991.

1. Gorter RW., Experience with viscum album (Iscador) and Marihuana (Dronabinol) in: AIDS, eine Krankheit wird behandelbar; Materialien zur HIV-Erkrankung im 2. Jahrzehnt, Ecomed, Band III, p 167 – 171, 1993

1. Gorter RW., Medikamentöse Beeinflußung von Stoffwechsel und Appetit, in: HIV-Medizin: Möglichkeiten der individualisierten Therapie. Wissenschaft-liche Ergebnisse in der mitte der 90er Jahre. Jäger (Hrsg.), Ecomed, Band IV, p. 233 – 238, 1994

1. Robert Gorter; I Dodici Sensi Dell’Homo, febbraio 1995, Assoziatione Amici della Scuola Steineriana, via Clevicetti 45, Milano, Italia

1. Gorter RW., Management of Anorexia-Cachexia Associated With Cancer and HIV-Infection, International Conference on Bioresource Hemp, Frankfurt, Germany, March 1995, Proceedings Vol. I

1. Gorter RW., el Arif N, Stoss M: Anthroposophische Medizin. In:
   Wolfstädter HD; Unkonventionelle Medizin bei HIV und AIDS. Hrsg.
   Deutsche AIDS-Hilfe e.V. Berlin, 1995.

1. Robert Gorter, La Biografia Umana. Settembre 1996, Assoziatione Amici della Scuola Steineriana, via Clevicetti 45, Milano, Italia.

1. Baumann E, Mandera R, Schnelle M, Zeh K, Stoss M, Gorter RW; Cannabis als Heilpflanze. Der Merkurstab, 1997, 50 (2), p. 94 – 103.

1. Grotenhermen F, Gorter RW: Cannabis und Psychosen. Der Merkurstab, (4) 231 – 237, 1997

1. Gorter, RW, Stoss M., Moderne Misteltherapie, Privatärztliche Praxis, 02 (4); p. 186 – 188,1997.

1. Gorter, Robert W, Cannabis bei Anorexie und Kachexie von Krebs- und AIDS-Patienten In: Cannabis und Cannabinoide als Medizin, ISBN 3-9805840-4-6, 1997

1. Robert Gorter; La Biografia Umana Parte I & II, settembre 1997/novembre 1998, Associazione Amici della Scuola Steineriana, via Clericetti 45, Milano, Italia

1. Gorter RW, Cannabis und chronische Schmerzen. In: Abstractband Der
   Deutsche Schmerztag 1998; 9. Deutscher interdisziplinärer Schmerzkongreß. p.26 – 28, Frankfurt am Main 4. – 8. März 1998.

1. Gorter RW, Stoss M; Immunmodulation und Krebstherapie. Moderne Mistel­therapie. Privatärztliche Praxis 1998, 2(6), p. 186 – 188

1. Stoss M, Gorter RW; Moderne Misteltherapie in der Onkologie. Pharmazeu-tische Rundschau. 1998, 8, p. 32-34

1. Stoss M, Robert W. Gorter; Die Iscador-Therapie in der Onkologie. Schweizerische Zeitschrift für GanzheitsMedizin, Jg. 11, Heft 2, März 1999, p 91-95.

1. Robert Gorter, I Sacrifici del Cristo, il Loro Significato per l’Evoluzione Umana e la Loro Ricapitolazione nel Perdono. Novembre 1998, Associazione Amici della Scuola Steineriana, via Clericetti 45, Milano, Italia.

1. Gorter R. Karnow G, Stoss M; Anthroposophical Medicine-Comprehensive Cancer Care. Center for Mind-Body Medicine, transcripts II, June 12th, 1999, Washington DC, USA

1. Wilfried Stücker, Robert W. Gorter, Dagmar Marx; Dendritische Zellen in der Tumortherapie. Naturheilpraxis Jg.56, Heft 3: 408-411, März 2003.

1. Robert Gorter, Erfahrungen mit Dronabinol (Delta 9 Tetrahydrocannabinol) bei onkologischen Patienten mit Anorexie-Kachexie-Syndrom in Der Schmerz (Dezember 2004) 18(suppl.2); S31-S33. Springer Verlag.

1. Robert W. Gorter: O cancro e uma doenca do Sistema Imunitario in Noticias Medicas Nr. 3001, September 10th, 2008. (O Jornal da Medicina Portuguesa).

 Abstracts

1. Brodie B., Gorter R., Chaisson RE., Moss AR., Volberding PA.,  Clinical care of IV drug users (IVDUs) with HIV infection. Program & Abstracts IVth International Conference on AIDS, June 12-16, 1988, Stockholm, Sweden, #8509.

1. Kocurek D., Bacchetti P., Gorter R., Moss A.,  HIV seropositivity in IVDU Vietnam combat veterans. Vth International Conference on AIDS, Montreal A525, page 165, June, 1989.

1. Moss A., Bacchetti P., Osmond D., Meakin R., Keffelew A., Gorter R., Seroconversion for HIV in intravenous drugs users in San Francisco.  VIth International Conference on AIDS, Montreal, Th. A. P. 102, page 157, June,1989.

1. Gorter R., Kocurek K., Brodie B., Bacchetti P., Ross E., Moss A., Progression of HIV disease in intravenous drug users. Vth International Conference on AIDS, Montreal, T.A.O. 11 page 56, June, 1989.

1. Vranizan K., Gorter R., Osmond D., et al.,  Laboratory markers for HIV in intravenous drugusers in San Francisco: Race and sex differences. VIth International Conference on AIDS, San Francisco, California, June, 1990 F.C. 554 Abstract Book Vol. II p. 219.

1. Moss A., Vranizan K., Bacchetti P., Gorter R., et al., Seroconversion for HIV in intravenous drug users in treatment, San Francisco 1985-1990.  VIth International Conference on AIDS, San Francisco, California, June, 1990. F.C. 553 Abstract Book Vol II p. 219.

1. Keffelew A., Clark G., Bacchetti P., Gorter R., et al.,  Use of needle exhange programs by San Francisco drug users in methadone treatment. VIth International Conference on AIDS, San Francisco, California, June, 1990. F.C. 107 Abstract Book Vol II p. 116.

1. Goldstein A,, Gavojdea S,, Gorter R., et al.,  Analysis of HIV antibodies in serum versus whole saliva. VIth International Conference on AIDS, San Francisco, California, June, 1990. S/C/613 Abstract Book Vol I p 272.

1. Wolfe H., Vranizan K., Gorter R., et al., Crack use and related risk factors in IVDUs in San Francisco. VIth International Conference on AIDS, San Francisco, California, June, 1990. Th.C. 591 Abstract Book Vol I p 273.

1. Gorter R., Vranizan K., Moss A., et al., Progression of HIV disease in intravenous drug users. VIth International Conference on AIDS, San Francisco, California, June, 1990. Th.C. 664 Abstract Book Vol I p. 286.

1. Slome L., Moulton J., Huffine C., Gorter R., et al., Physician’s attitudes toward assisted suicide in AIDS. VIth International Conference on AIDS, San Francisco, California, June 1990.

1. Abrams D., Greco M., Wong R., Goosby E., Gorter R., et al., Results of a phase I/II placebo-controlled dose finding pilot study of lentinan in patients with HIV infection. VIth International Conference on AIDS, San Francisco, California, San Francisco, June 1990. S.B.487 Abstract Book Vol III p 207

1. Williams A., Vranizan K., Gorter R., et al., Methadone maintenance, HIV serostatus and race in injection drug users (IDU) in San Francisco, CA. VIth International Conference on AIDS San Francisco, California, June 1990. S.C. 748 Abstract Book Vol III p 276.

1. Gorter R., Osmond D., Galli D., Hanson C., Vranizan K., Moss A.,  Co-infection of HIV-1 and HTLV-I/II on intravenous drug users in treatment programs in San Francisco. VIIth International Conference on AIDS, Florence, Italy, June 1991. M.C. 2372, p 366 Abstract Book Vol I.

1. Wolfe H., Hannah, Zolopa A., Kefflew A., Meakin R., Gorter R., Miranda J., Psychiatric disorder and HIV infection among San Francisco Homeless. VIIth International Conference on AIDS Florence, Italy, June 1991. W.D. 4043, p. 398 Abstract Book Vol II.

1. Zolopa A., Gorter R., Meakin R., Kefflew A., Wolfe H., Moss A., Homelessness and HIV infection: a population based study. VIIth International Conference on AIDS, Florence, Italy, June 1991. M.C. 3244, p. 359, Abstract Book Vol I.

1. Plasse T., Connant M., Gorter R., Sheperd K., Dronabinol stimulates appetite and causes weight gain in HIV patients. VIIIth International Conference on AIDS, Amsterdam, Netherlands, July 1992. PuB 7442, p.122, Abstract Book.

1. Gorter R., Khwaja T., Linder M., Anti-HIV and immunomodulating activities of Viscum album (mistletoe). VIIIth International Conference on AIDS,
   Amsterdam, Netherlands, July 1992. PuB 7214, p.84, Abstract Book.

1. Tappero J., Gorter R., Fila D., Child C., Mitchell T., Alpha-interferron for severe HIV-associated molluscum contagiosum. VIIIth International Conference on AIDS, Amsterdam, Netherlands, July 1992, PoB 3886, p.238,
   Abstract Book.

1. Gorter R., Stoss M., El Arif N., Labonte B., Beckmann C., Anti-HIV and
   immunomodulating activities of Viscum album (Iscador®). IXth International Conference on AIDS, Berlin, Germany, June 1993. PO-B28-2167, p. 496,
   Abstract Book Vol. I.

1. Gorter R., Stoss M., Stein J., el Arif N., Immunomodulating and anti-HIV activities of Iscador. Scientific advances in complemantary medicine, Padova, Italy, June 1995

1. Gorter R., Double-blind, placebo controlled parallel study to document the effect of delta-9-THC on appetite and weight in symptomatic HIV-infection and AIDS. 5. Münchner AIDS-Tage, München, Germany, Jan. 1996. In: AIDS und HIV-Infektion in Klinik und Praxis: Vol. 5; 226 – 227

1. Gorter R., Bestimmung der Virusbelastung mittels branched-DNA bei HIV-Positiven mit Iscador QuFrF-Behandlung. 5. Münchner AIDS-Tage, München, Germany, Jan. 1996. In: AIDS und HIV-Infektion in Klinik und Praxis: Vol. 5; 228 – 229

1. Gorter RW., Stein J., Stoss M., Schuler C., Phase II study to document anti-HIV efficacy of Iscador QuFrF (Viscum album L.). First European Conference on Experimental AIDS Research. Abstract Book; 196 – PS6, Cannes, France, Jan. 1996

1. Heinzerling L., Rotty J., van Wely M., Portalupi E., Gorter R.,  Prospective Phase-III Studie zur Bestimmung der krebshemmenden und immun-modulierenden Wirkung von Iscador®-Qu Spezial bei Patientinnen mit Cervixdysplasie. Conference on Unconventional Medicine. BMFT, Abstract Book, p. 47, Bonn Germany, Dec. 1997

1. Gorter, RW., Cannabis sativa in der medizinischen Betreuung von Drogen- gebrauchern/innen. 6. Deutscher AIDS-Kongreß, Abstract Book; V156, p. 46, München, Germany, Oct. 1996

1. Gorter RW., Prospektive longitudinale Phase-III-Studie zur Bestimmung der präventiven und krebshemmenden Wirkung von Iscador Qu Spezial bei
   Patientinnen mit Cervixdysplasien. Bundesministerium für Forschung und Technik: Workshop „Unkonventionelle medizinische Richtungen und unkonventionelle Methoden der Krebsbekämpfung“, Bad Honnef am 23. und 24.
   Februar 1996. In: Forsch Komplementärmed (4) 58 – 68, 1997.

1. Gorter RW., Cannabis and HIV wasting. Third international conference on home and community care for persons living with HIV/AIDS, Abstract Book; O179, Amsterdam, May 1997

1. van Wely M., Stoss M., Gorter RW., Open Label phase-II trial to document immunomodulating and anti-HIV activities of Iscador QuFrF in HIV positives. Abstract book 190-P4. 2 nd European conference on Experimental AIDS
   Research Stockholm, Sweden, June, 1997

1. Gorter RW., Schnelle M., Stoss M., van Wely M; Cannabis and wasting in AIDS and cancer. International 1997 Symposium on the Cannabinoids,
   Abstract Book, p. 87, Atlanta, USA, June 1977

1. Schnelle M., Stoss M., van Wely M., Gorter RW.; Cannabis zur Behandlung von Anorexie / Kachexie bei AIDS-Patienten – Toxikologische Aspekte. In: Neue Perspektiven Therapeutische Erwartungen; Die Realität 1997; Monographienreihe Band 6, p. 232 – 236, München July 1977

1. van Wely M., Stoss M., Gorter RW.; Open-Label Phase-II-Studie zur
   Bestimmung der immunmodulierenden und antiviralen Wirkungen von Iscador QuFrF bei HIV-Positiven Patienten.. In: Neue Perspektiven Therapeutische Erwartungen; Die Realität 1997; Monographienreihe Band 6, p. 243 – 244, München July 1977

1. Gorter RW., Rotty J., Heinzerling L., Schnelle M.; The immunomodulating activities of Iscador Qu Spezial (Viscum album) in patients with HPV-associated cervical dysplasia. In: Abstract Book, First Polish Scientific Conference on Colposcopy and Cervix Dysplasia, p. 217. Zakopane, March 1998
2. Gorter, Robert W., Viscum album L. (aqueous extract) as an immunomodulator and antiviral drug in HIV. A phase II trial. 12Th World AIDS Conference Geneva, Switzerland. 1998, Abstract 44323, Abstract Book

1. Robert Gorter, Matthias Stoss, Ellen Peter, Danyl Soto-Vera, Prospective, open-label Phase-II-Study to document the immunomodulatory and anti-HIV-activity of VaQuFrF in HIV-positives over 11 months. Eur J Med Res 4
   (suppl 1); 10, 1999

1. I. Sanne, D. Spencer, R. Smego, R. Gorter, Immunomodulation of VaQuFrF as adjuvant therapy in combination with Zidovudine and Lamiduvine in HIV-therapy. Eur J Med Res 4 (suppl 1); 10, 1999

1. Robert W. Gorter, Matthias Stoss, Danyl Soto-Vera, No evidence of IFN-g increase in the serum of HIV-positive and healthy subjects after subcutaneous injection of a non-fermented Viscum album L. extract. Eur J Med Res 4
   (suppl 1); 58, 1999.

1. Robert W. Gorter, A whole-plant Cannabis extract for anorexia / cachexia in cancer patients. Yoint Meeting British and German Pharmacological Societies Nottingham, UK, July 1999, Abstractbook page 8.

1. Robert W. Gorter,  An observational study with Medical Grade Marijuana (MGM) in the Netherlands, International Cannabinoid Research Society, Abstractbook, page 111, Baltimore, June 22nd-24th, 2000.

1. Robert W. Gorter, Possible anti-cancer and anti-retroviral activities of Sutherlandia. Abstract Book, page 45. 38th annual meeting Drug Information Association, Chigaco, USA, June 16th -21st, 2002.

1. Gorter RW, Practical medical applications of Cannabis and Cannabinoids. Archiv der Pharmazie Vol. 335 (Suppl. 1) page 30, September 2002.

1. Killerstein J, Hoogervorst ECJ, Reif M, Kalkers NF, Van Loenen AC, Staats PGM, Gorter RW, Uitdehaad BMJ, Polman CM: Safety, tolerability and efficacy of orally administered cannabinoids in multiple sclerosis: a randomized, double-blind, placebo-controlled. Two-fold cross-over study. Multiple Sclerosis, Vol 7, suppl 1, September 2001 (platform presentation 0-35).

1. Matthes C, Marx D, Cillien C, Gorter R, Lorenzen D, Peters H, Nesselhut T: Marker expression of monocyte-derived dendritic cells in healthy individuals and cancer patients; correlation to clinical response. 39th annual meeting of the American Society of Clinical Oncology, Proceedings of ASCO, page 180, #723, Chicago, May 31st-June 4th, 2003.

1. T Nesselhut, R Chang, C Matthes, D Marx, D Lorenzen, N Cillien, M Martin, R Gorter, J Peters: Cancer therapy with unloaded monocyte-derived dendritic cells in patients with inoperable pancreatic and gall bladder cancer. 40th Annual meeting of the American Society of Clinical Oncology, proceedings of ASCO, page 180, #2569, New Orleans, USA, June 5th-8th, 2004.

1. Robert Gorter, Eloy Pulido, Mario Butorac: “Fever-Range, Total-Body Hyperthermia in Combination with Autologous Dendritic Cells in Cancer Patients” The Kadota Fund International Forum, Awaji Yumebutai International Congres, Awaji Islands, Hyogo, Japan, Abstract Book, page 41, #20, June 14th -18th, 2004.

1. Thomas Nesselhut, Constanze Matthes, Dagmar Marx, Raymond Chang, Dirk Lorenzen, Robert Gorter, Hinrich Peters: Cancer therapy with immature monocyte-derived dendritic cells in patients with advanced breast cancer. 41st Annual Meeting of the American Society of Clinical Oncology, proceedings of ASCO, Orlando, USA, May 11th – 15th, 2005.

1. Robert W. Gorter, MD, PhD, et al, “Clinical Outcome of Vaccinations with Naïve (Non-Pulsed) Dendritic Cells in Patients with Recurrent Glioblastome Multiforme in Combination with Electro-Capacitivce Hyperthermia (Celsius 42+)” Delhi State Cancer Institute, Delhgi, India, page 23, December 22nd & 23rd, 2012.